Literature DB >> 28807425

Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.

Amarjeet Kaur1, Sumanth Gandra2, Priyanka Gupta1, Yatin Mehta3, Ramanan Laxminarayan4, Sharmila Sengupta5.   

Abstract

In this study, we retrospectively evaluated clinical outcomes of 75 patients with dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections over a 5-year period in a single tertiary care hospital in India. We observed a high in-hospital mortality rate of 69.3%. Our findings indicate the urgent need for new antibiotics to treat these infections.
Copyright © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem resistance; Colistin resistance; India; Klebsiella

Mesh：

Substances：

Year:  2017        PMID： 28807425     DOI： 10.1016/j.ajic.2017.06.028

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  7 in total

1.  Molecular prevalence of resistance determinants, virulence factors and capsular serotypes among colistin resistance carbapenemase producing Klebsiella pneumoniae: a multi-centric retrospective study.

Authors:  Aradhana Das; Rajesh Kumar Sahoo; Mahendra Gaur; Suchanda Dey; Saubhagini Sahoo; Anshuman Sahu; Dibyajyoti Uttameswar Behera; Sangita Dixit; Pooja Singhvi Jain; Bhawana Jain; Kundan Kumar Sahu; K Swapna Kumari; Enketeswara Subudhi
Journal:  3 Biotech       Date:  2021-12-28       Impact factor: 2.406

2.  Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far.

Authors:  Kamini Walia; Jayaprakasam Madhumathi; Balaji Veeraraghavan; Arunaloke Chakrabarti; Arti Kapil; Pallab Ray; Harpreet Singh; Sujatha Sistla; V C Ohri
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

Review 3.  Understanding policy dilemmas around antibiotic use in food animals & offering potential solutions.

Authors:  Kamini Walia; Monica Sharma; Sonam Vijay; Bibek R Shome
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

4.  Triple Versus Double Therapy for the Treatment of Severe Infections Caused by Carbapenem-Resistant Enterobacteriaceae: A Systematic Review and Meta-Analysis.

Authors:  Lei Wang; Xiang Tong; Jizhen Huang; Li Zhang; Dongguang Wang; Man Wu; Tao Liu; Hong Fan
Journal:  Front Pharmacol       Date:  2020-01-30       Impact factor: 5.810

5.  Antibiotic resistance: Global health crisis and metagenomics.

Authors:  Shailendra Yadav; Atya Kapley
Journal:  Biotechnol Rep (Amst)       Date:  2021-02-23

Review 6.  A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.

Authors:  Sanjeev Singh; Esmita Charani; Sarada Devi; Anuj Sharma; Fabia Edathadathil; Anil Kumar; Anup Warrier; P S Shareek; A V Jaykrishnan; K Ellangovan
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-11       Impact factor: 4.887

7.  Will There Ever Be Cure for Chronic, Life-Changing Colistin-Resistant Klebsiella pneumoniae in Urinary Tract Infection?

Authors:  Aye Mya Sithu Shein; Parichart Hongsing; Shuichi Abe; Sirirat Luk-In; Naveen Kumar Devanga Ragupathi; Dhammika Leshan Wannigama; Tanittha Chatsuwan
Journal:  Front Med (Lausanne)       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.